2‐Hydroxyethyl methacrylate (2‐HEMA) sensitization, a global epidemic at its peak in Spain?

Maria Elena Gatica‐Ortega,Maria Antonia Pastor‐Nieto,Ana María Giménez‐Arnau,Pedro Mercader‐García,Tatiana Sanz‐Sánchez,José Manuel Carrascosa‐Carrillo,Susana Córdoba‐Guijarro,Javier Sánchez‐Pérez,Juan Francisco Silvestre,Francisco Javier Ortiz‐de Frutos,Fátima Tous‐Romero,Virginia Fernández‐Redondo,Esther Serra‐Baldrich,Inmaculada Ruíz‐González,Ricardo González Pérez,Javier Miquel‐Miquel,Paloma Sánchez‐Pedreño Guillén,Marcos Hervella‐García,Felipe Heras‐Mendaza,Enrique Gómez‐de‐la‐Fuente,Violeta Zaragoza‐Ninet,Araceli Sánchez Gilo,Mercedes Rodríguez‐Serna,Gemma Melé‐Ninot,Miguel Ángel Descalzo,Marina de‐Vega,Ignacio García‐Doval,Leopoldo Borrego
DOI: https://doi.org/10.1111/cod.14520
2024-02-15
Contact Dermatitis
Abstract:(Meth)acrylate sensitization is a prevalent health issue in Spain. 2‐HEMA 2% pet. has been identified to be a highly effective (meth)acrylate allergy marker. The responsible authorities should implement policies guaranteeing accurate labelling of industrial, medical, and consumer materials while ensuring the enforcement of said labelling through appropriate legal means. Background A global epidemic of allergic contact dermatitis to (meth)acrylates has been described in relation to the widespread use of manicure products. Objectives To evaluate the frequency of sensitization to 2‐hydroxyethyl methacrylate (2‐HEMA) among consecutively patch tested patients with eczema in Spain; the percentage of current relevance; the MOAHLFA index; and, the potential sources of exposure to (meth)acrylates. Methods From January 2019 to December 2022, 2‐HEMA 2% pet. was prospectively patch tested in 24 REIDAC (Spanish Allergic Contact Dermatitis Registry) centres. Results Six thousand one hundred thirty‐four patients were consecutively patch tested with 2‐HEMA 2% pet. 265/6134 (4.3%) were positive. Positive reactions of current relevance were identified to involve 184/265 (69%). The efficiency (number of patch tests needed to detect relevant positive patch test reactions) was 34 (6134/184). The variable 'occupational' was found to be significantly associated with a higher risk for relevant positive reactions to 2‐HEMA (OR: 10.9; 95% CI: 8.1–14.9). Conclusion (Meth)acrylate sensitization is a prevalent health issue in Spain. 2‐HEMA 2% pet. has been identified to be a highly effective (meth)acrylate allergy marker in the GEIDAC baseline series. The responsible authorities should implement policies guaranteeing accurate labelling of industrial, medical, and consumer materials while ensuring the enforcement of said labelling through appropriate legal means.
dermatology,allergy
What problem does this paper attempt to address?